Cellebrite (CLBT) PT Raised to $26 at Lake Street Capital Markets
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CLBT Hot Sheet
Price: $12.25 --0%
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 12
Rating Summary:
10 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 23 | New: 12
Join SI Premium – FREE
Lake Street Capital Markets analyst Eric Martinuzzi raised the price target on Cellebrite (NASDAQ: CLBT) to $26.00 (from $17.00) while maintaining a Buy rating.
You May Also Be Interested In
- Abbvie (ABBV) PT Raised to $340 at BMO Capital
- Westpac Banking Corp. (WBC:AU) (WBK) PT Lowered to AUD41.50 at UBS
- Amgen (AMGN) PT Raised to $531 at TD Cowen
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
